Le Lézard
Classified in: Health
Subjects: AVO, CPG

Cancellation of Edmonton Hub Lab Will Expand Existing Gaps in Healthcare Access Across Alberta, Reports Canadian Laboratory Professionals


EDMONTON, July 24, 2019 /CNW/ - The Canadian Society for Medical Laboratory Science (CSMLS) announced their request of the Government of Alberta to invest in new infrastructure amid the recent cancellation of a $595 million-dollar medical superlab in Edmonton. New investment is needed in medical laboratory facilities across the province to help alleviate a growing shortage of services available primarily in Edmonton and Northern Alberta.

Logo: Canadian Society for Medical Laboratory Science (CNW Group/Canadian Society for Medical Laboratory Science)

"In light of this recent decision, investments today from the Government of Alberta would help to solve the major inefficiencies of our current system and deliver faster quality patient care for less in the long run," says Joel Rivero, CSMLS Alberta Director. "Restrictions on physical space for our staff and equipment restricts Alberta's labs from running at their full potential. Investment is absolutely critical moving forward, as ultimately patients are left with the consequences of this decision."

In Canada, medical laboratory professionals perform over 440 million tests every year, tens of millions of which are in Alberta. With the information provided in these test results, doctors are able to make accurate, informed medical decisions to diagnose and treat their patients. However, the current state of Alberta medical laboratories is causing serious gaps in service. From finding adequate space for equipment to run without over heating, to sending samples to multiple locations for testing, medical laboratory services increasingly struggle to keep up with growing demands.

Future medical laboratory investment would allow medical laboratory professionals to deliver more efficient testing to northern Alberta communities which are facing a severe shortage of qualified laboratory professionals. 

"The current shortage is already having an impact in rural and remote communities across the province," says CSMLS CEO Christine Nielsen. "Compounded with the decision not to proceed with this new site, the problem will only grow. We are calling on the Government to deliver facility investments across Alberta to increase the efficiency of current testing and deliver more results to remote communities for less."

The CSMLS is prepared to work with the Government of Alberta to maximize future investment in medical laboratories.

About CSMLS
The Canadian Society for Medical Laboratory Science is the national certifying body for medical laboratory technologists and medical laboratory assistants and the national professional society for Canada's medical laboratory professionals. Incorporated in 1937 as the Canadian Laboratory Technologists, the society has over 14,000 members in Canada and in countries around the world.

 

SOURCE Canadian Society for Medical Laboratory Science


These press releases may also interest you

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...

at 07:05
Mind Medicine (MindMed) Inc. , (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study...

at 07:05
Mission Bio, a leader in single-cell multiomic solutions for precision medicine, today announced the launch of a new single-cell capability that enhances our understanding of translocations (chromosomal rearrangements) in gene-edited therapies....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline developments relating to the RASP modulation platform and ADX-2191 for the...



News published on and distributed by: